Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xianglian capsule for diarrhea after cholecystectomy
ChiCTR2200061854Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Guangdong Medical University
- Start
- Jun 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of xianglian capsule in diarrhea (2 arms), sponsored by Second Affiliated Hospital of Guangdong Medical University. Primary endpoints: Inflammatory cytokines and Intestinal flora. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
xianglian capsule
03
Conditions
diarrhea
Beyond the preview
Go deeper on ChiCTR2200061854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061854.